trending Market Intelligence /marketintelligence/en/news-insights/trending/7lC5Ogh6nxSHdyNay6_tiw2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Dextera Surgical expects to delist from Nasdaq

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Dextera Surgical expects to delist from Nasdaq

Dextera Surgical Inc. said it does not intend to appeal Nasdaq's determination that it is not in compliance with the minimum $2.5 million stockholders' equity requirement for continued listing.

As a result, the company expects trading in its stock to be suspended on Oct. 26, and for the stock to be removed from listing and registration on Nasdaq.

The company decided not to submit an appeal due to the amount of the stockholders' deficit, the prospects for regaining compliance and the cost of the appeals process.

Dextera said it has applied to the OTC Markets Group for a listing of its common stock on the OTCQB venture market.